当前位置: 首页 >> 检索结果
541. A pilot study of the noninvasive assessment of the lung microbiota as a potential tool for the early diagnosis of ventilator-associated pneumonia.
作者: Addison K May.;Jacob S Brady.;Joann Romano-Keeler.;Wonder P Drake.;Patrick R Norris.;Judith M Jenkins.;Richard J Isaacs.;Erik M Boczko.
来源: Chest. 2015年147卷6期1494-1502页
Ventilator-associated pneumonia (VAP) remains a common complication in critically ill surgical patients, and its diagnosis remains problematic. Exhaled breath contains aerosolized droplets that reflect the lung microbiota. We hypothesized that exhaled breath condensate fluid (EBCF) in hygroscopic condenser humidifier/heat and moisture exchanger (HCH/HME) filters would contain bacterial DNA that qualitatively and quantitatively correlate with pathogens isolated from quantitative BAL samples obtained for clinical suspicion of pneumonia.
542. Comparison of hospital mortality and long-term survival in patients with acute lung injury/ARDS vs cardiogenic pulmonary edema.
作者: Christopher N Schmickl.;Michelle Biehl.;Gregory A Wilson.;Ognjen Gajic.
来源: Chest. 2015年147卷3期618-625页
Early differential diagnosis of acute lung injury (ALI) vs cardiogenic pulmonary edema (CPE) is important for selecting the most appropriate therapy, but the prognostic implications of this distinction have not been studied. Accurate prognostic information is essential for providing appropriate informed consent prior to initiation of mechanical ventilation.
543. Supplementing defect in club cell secretory protein attenuates airway inflammation in COPD.
作者: Anne Sophie Gamez.;Delphine Gras.;Aurélie Petit.;Lucie Knabe.;Nicolas Molinari.;Isabelle Vachier.;Pascal Chanez.;Arnaud Bourdin.
来源: Chest. 2015年147卷6期1467-1476页
Club cell secretory protein (CCSP) is a protective biomarker associated with annual decline in lung function. COPD progression results from an imbalance between injury and repair initially triggered by cigarette smoking.
553. A survey of Japanese thoracic oncologists' perception of diagnostic and treatment strategies for EGFR mutant or EML4-ALK fusion non-small cell lung cancer.
作者: Katsuyuki Hotta.;Katsuyuki Kiura.;Masahiro Tabata.;Nagio Takigawa.;Mitsune Tanimoto.;Hiroshi Ueoka.
来源: Chest. 2014年146卷6期e222-e225页 555. Dual-time point whole-body 18F-fluorodeoxyglucose PET/CT imaging in undiagnosed mediastinal lymphadenopathy: a prospective study of 117 patients with sarcoidosis and TB.
作者: Venkata Nagarjuna Maturu.;Ritesh Agarwal.;Ashutosh Nath Aggarwal.;Bhagwant Rai Mittal.;Amanjit Bal.;Nalini Gupta.;Dheeraj Gupta.
来源: Chest. 2014年146卷6期e216-e220页 |